with this therapeutic approach, including selection of the appropriate transgene to express, titration of the amount of gene expression to provide the desired eYcacy, and long term safety.

References

Acott, T. S. (1992). Trabecular extracellular matrix regulation. In ‘‘Pharmacology of Glaucoma’’ (S. M. Drance, E. M. Van Buskirk, and A. H. Neufeld, eds.), pp. 125–127. Williams & Wilkins, Baltimore.

Acott, T. S., Kingsley, P. D., Samples, J. R., and Van Buskirk, E. M. (1988). Human trabecular meshwork organ culture: Morphology and glycosaminoglycan synthesis. Invest. Ophthalmol. Vis. Sci. 29, 90–100.

Adkins, J. C., and Balfour, J. A. (1998). Brimonidine. A review of its pharmacological properties and clinical potential in the management of open angle glaucoma and ocular hypertension.

Drugs Aging 12, 225–241.

AGIS Investigators. (2000). The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130, 429–440.

Aihara, M., Lindsey, J. D., and Weinreb, R. N. (2003). Ocular hypertension in mice with a targeted type I collagen mutation. Invest. Ophthalmol. Vis. Sci. 44, 1581–1585.

Alexander, R. A., Grierson, I., and Church, W. H. (1989). The eVect of argon laser trabeculoplasty upon the normal human trabecular meshwork. Graefes Arch. Clin. Exp. Ophthalmol. 227, 72–77.

Alexander, J. P., Samples, J. R., Van Buskirk, E. M., and Acott, T. S. (1991). Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 32, 172–180.

Alexander, J. P., Samples, J. R., and Acott, T. S. (1998). Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr. Eye Res. 17, 276–285.

Alvarado, J., Murphy, C., and Juster, R. (1984). Trabecular meshwork cellularity in primary open angle glaucoma and nonglaucomatous normals. Ophthalmology 91, 564–579.

Alvarado, J. A., Alvarado, R. G., Yeh, R. F., Franse Carman, L., Marcellino, G. R., and Brownstein, M. J. (2005). A new insight into the cellular regulation of aqueous outflow: How trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm’s canal endothelial cells. Br. J. Ophthalmol. 89, 1500–1505.

Ando, H., Twining, S. S., Yue, B. Y., Zhou, X., Fini, M. E., Kaiya, T., Higginbotham, E. J., and Sugar, J. (1993). MMPs and proteinase inhibitors in the human aqueous humor. Invest. Ophthalmol. Vis. Sci. 34, 3541–3548.

Avila, M. Y., Stone, R. A., and Civan, M. M. (2001). A1 , A2A and A3 subtype adenosine receptors modulate intraocular pressure in the mouse. Br. J. Pharmacol. 134, 241–245.

Avila, M. Y., Stone, R. A., and Civan, M. M. (2002). Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Iovs 43, 3021–3026.

Babizhayev, M. A., and Brodskaya, M. W. (1989). Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open angle glaucoma. Mech. Ageing Dev. 47, 145–157.

Bachmann, B., Birke, M., Kook, D., Eichhorn, M., and Lu¨tjen Drecoll, E. (2006). Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest. Ophthalmol. Vis. Sci. 47, 2011–2020.

Bahler, C. K., Hann, C. R., Fautsch, M. P., and Johnson, D. H. (2004). Pharmacologic disruption of Schlemm’s canal cells and outflow facility in anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 45, 2246–2254.

Ba´ra´ny, E. H. (1964). Simultaneous measurements of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest. Ophthalmol. Vis. Sci. 2, 135–143.

Ba´ra´ny, E. H., and Scotchbrook, S. (1954). Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol. Scand. 30, 240–248.

Bengtsson, B., Leske, M. C., Hyman, L., Heijl, A., and Early Manifest Glaucoma Trial Group. (2007). Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 114, 205–209.

Bergea, B., Bodin, L., and Svedbergh, B. (1999). Impact of intraocular pressure regulation on visual fields in open angle glaucoma. Ophthalmology 106, 997–1005.

Bhattacharya, S. K., Annangudi, S. P., Salomon, R. G., Kuchtey, R. W., Peachey, N. S., and Crabb, J. W. (2005a). Cochlin deposits in the trabecular meshwork of the glaucomatous DBA/2J mouse. Exp. Eye Res. 80, 741–744.

Bhattacharya, S. K., Rockwood, E. J., Smith, S. D., Bonilha, V. L., Crabb, J. S., Kuchtey, R. W., Robertson, N. G., Peachey, N. S., Morton, C. C., and Crabb, J. W. (2005b). Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork. J. Biol. Chem. 280, 6080–6084.

Bhattacherjee, P., Paterson, C. A., and Percicot, C. (2001). Studies on receptor binding and signal transduction pathways of unoprostone isopropyl. J. Ocul. Pharmacol. Ther. 17, 433–441.

Bill, A. (1966). Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp. Eye Res. 5, 45–54.

Bill, A. (1975). Editorial: The drainage of aqueous humor. Invest. Ophthalmol. 14, 1–3. Borras, T., Rowlette, L. L., Erzurum, S. C., and Epstein, D. L. (1999). Adenoviral reporter gene

transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma. Gene Ther. 6, 515–524.

Borras, T., Gabelt, B. T., Klintworth, G. K., Peterson, J. C., and Kaufman, P. L. (2001). Non invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J. Gene Med. 3, 437–449.

Borras, T., Xue, W., Choi, V. W., Bartlett, J. S., Li, G., Samulski, R. J., and Chisolm, S. S. (2006). Mechanisms of AAV transduction in glaucoma associated human trabecular meshwork cells. J. Gene Med. 8, 589–602.

Bradley, J. M., Vranka, J., Colvis, C. M., Conger, D. M., Alexander, J. P., Fisk, A. S., Samples, J. R., and Acott, T. S. (1998). EVect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest. Ophthalmol. Vis. Sci. 39, 2649–2658.

Bradley, J. M., Anderssohn, A. M., Colvis, C. M., Parshley, D. E., Zhu, X. H., Ruddat, M. S., Samples, J. R., and Acott, T. S. (2000). Mediation of laser trabeculoplasty induced matrix metalloproteinase expression by IL 1beta and TNFalpha. Invest. Ophthalmol. Vis. Sci. 41, 422–430.

Bylsma, S. S., Samples, J. R., Acott, T. S., and Van Buskirk, E. M. (1988). Trabecular cell division after argon laser trabeculoplasty. Arch. Ophthalmol. 106, 544–547.

Cai, S., Liu, X., Glasser, A., Croft, M. A., Polansky, J. R., Fauss, D. J., and Kaufman, P. L. (1999). Latrunculin (Lat) A eVects on human trabecular meshwork (HTM) cells. Invest. Opthalmol. Vis. Sci. 40, S505.

Cai, S., Liu, X., Glasser, A., Volberg, T., Filla, M., Geiger, B., Polansky, J. R., and Kaufman, P. L. (2000). EVect of latrunculin A on morphology and actin associated adhesions of cultured human trabecular meshwork cells. Mol. Vis. 6, 132–143.

Cao, Y., Wei, H., PfaZ, M. W., and Da, B. (2003). EVect of transforming growth factor beta 2 on phagocytosis in cultured bovine trabecular meshwork cells. Ophthalmologe 100, 535–538.

Caprioli, J. (2007). Intraocular pressure fluctuation: An independent risk factor for glaucoma?

Arch. Ophthalmol. 125, 1124–1125.

Chang, B., Smith, R. S., Peters, M., Savinova, O. V., Hawes, N. L., Zabaleta, A., Nusinowitz, S., Martin, J. E., Davisson, M. L., Cepko, C. L., Hogan, B. L., and John, S. W. (2001). HaploinsuYcient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet. 2, 18.

Chen, Y., Whetstone, H. C., Youn, A., Nadesan, P., Chow, E. C., Lin, A. C., and Alman, B. A. (2007). Beta catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 282, 526–533.

Chidlow, G., Hiscott, P. S., and Osborne, N. N. (2004). Expression of serotonin receptor mRNAs in human ciliary body: A polymerase chain reaction study. Graefes Arch. Clin. Exp. Ophthalmol. 242, 259–264.

Choi, J., Miller, A. M., Nolan, M. J., Yue, B. Y., Thotz, S. T., Clark, A. F., Agarwal, N., and Knepper, P. A. (2005). Soluble CD44 is cytotoxic to trabecular meshwork and retinal ganglion cells in vitro. Invest. Ophthalmol. Vis. Sci. 46, 214–222.

Civan, M. M. (2003). The fall and rise of active chloride transport: Implications for regulation of intraocular pressure. J. Exp. Zool. 300a, 5–13.

Civan, M. M., and Macknight, A. D. (2004). The ins and outs of aqueous humour secretion.

Exp. Eye Res. 78, 625–631.

Clark, A. F. (1998). New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest. Ophthalmol. Vis. Sci. 39, 2514–2516.

Clark, A. F., Wilson, K., McCartney, M. D., Miggans, S. T., Kunkle, M., and Howe, W. (1994). Glucocorticoid induced formation of cross linked actin networks in cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 35, 281–294.

Clark, A. F., Miggans, S. T., Wilson, K., Browder, S., and McCartney, M. D. (1995). Cytoskeletal changes in cultured human glaucoma trabecular meshwork cells. J. Glaucoma 4, 183–188.

Clark, A. F., Steely, H. T., Dickerson, J. E., Jr., English Wright, S., Stropki, K., McCartney, M. D., Jacobson, N., Shepard, A. R., Clark, J. I., Matsushima, H., Peskind, E. R., Leverenz, J. B., et al. (2001). Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest. Ophthalmol. Vis. Sci. 42, 1769–1780.

Clark, A. F., Brotchie, D., Read, A. T., Hellberg, P., English Wright, S., Pang, I. H., Ethier, C. R., and Grierson, I. (2005). Dexamethasone alters F actin architecture and promotes cross linked actin network formation in human trabecular meshwork tissue.

Cell Motil. Cytoskeleton 60, 83–95.

Clark, A. F., Millar, J. C., Pang, I. H., Jacobson, N., and Shepard, A. (2006). Adenoviral gene transfer of active human transforming growth factor b2 induces elevated intraocular pressure in rats. ARVO Abstract 4771.

Clark, A. F., McNatt, L. G., Hellberg, P. E., Millar, J. C., Rubin, J. S., Pang, I. H., and Wang, W. H. (2007). A functional Wnt pathway in the trabecular meshwork that regulates intraocular pressure. ARVO Abstract 1142.

CNTGS Group. (1998). Comparison of glaucomatous progression between untreated patients with normal tension glaucoma and patients with therapeutically reduced intraocular pressures. Am. J. Ophthalmol. 126, 487–497.

Crosson, C. E. (1992). Ocular hypotensive activity of the adenosine agonist (R) phenylisopropyladenosine in rabbits. Curr. Eye Res. 11, 453–458.

Crosson, C. E. (1995). Adenosine receptor activation modulates intraocular pressure in rabbits.

J. Pharmacol. Exp. Ther. 273, 320–326.

Crosson, C. E. (2001). Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: Evidence for a dual mechanism of action. Invest. Opthalmol. Vis. Sci. 42, 1837–1840.

Crosson, C. E., and Gray, T. (1994). Modulation of intraocular pressure by adenosine agonists.

J. Ocul. Pharmacol. 10, 379–383.

Crosson, C. E., and Gray, T. (1996). Characterization of ocular hypertension induced by adenosine agonists. Invest. Ophthalmol. Vis. Sci. 37, 1833–1839.

Crosson, C. E., Sloan, C. F., and Yates, P. W. (2005). Modulation of conventional outflow facility by the adenosine A1 agonist N6 cyclohexyladenosine. Invest. Ophthalmol. Vis. Sci. 46, 3795–3799.

Dan, J., Belyea, D., Gertner, G., Leshem, I., Lusky, M., and Miskin, R. (2005). Plasminogen activator inhibitor 1 in the aqueous humor of patients with and without glaucoma. Arch. Ophthalmol. 123, 220–224.

Dickerson, J. E., Jr., Steely, H. T., Jr., English Wright, S. L., and Clark, A. F. (1998). The eVect of dexamethasone on integrin and laminin expression in cultured human trabecular meshwork cells. Exp. Eye Res. 66, 731–738.

Do, C. W., and Civan, M. M. (2004). Basis of chloride transport in ciliary epithelium. J. Membr. Biol. 200, 1–13.

Do, C. W., and Civan, M. M. (2006). Swelling activated chloride channels in aqueous humour formation: On the one side and the other. Acta Physiol. 187, 345–352.

Ethier, C. R., Read, A. T., and Chan, D. W. (2006). EVects of latrunculin B on outflow facility and trabecular meshwork structure in human eyes. Invest. Ophthalmol. Vis. Sci. 47, 1991–1998.

Fan, H., Rao, S. K., Zhou, Y. S., and Lam, D. S. (2005). EVect of latrunculin B on intraocular pressure in the monkey eye. Arch. Ophthalmol. 123, 1456–1457.

Feng, Z., Mohapatra, S., Klimko, P. G., Hellberg, M. R., May, J. A., Kelly, C., Williams, G., McLaughlin, M. A., and Sharif, N. A. (2007). Novel benzodifuran analogs as potent 5 HT2A receptor agonists with ocular hypotensive activity. Bioorg. Med. Chem. Lett. 17, 2998–3002.

Fleenor, D. L., Pang, I. H., and Clark, A. F. (2003). Involvement of AP 1 in interleukin 1alpha stimulated MMP 3 expression in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 44, 3494–3501.

Fleenor, D. L., Shepard, A. R., Hellberg, P. E., Jacobson, N., Pang, I. H., and Clark, A. F. (2006). TGF beta 2 induced changes in human trabecular meshwork: Implications for intraocular pressure. Invest. Ophthalmol. Vis. Sci. 47, 226–234.

Fleischhauer, J. C., Mitchell, C. H., Stamer, W. D., Karl, M. O., Peterson Yantorno, K., and Civan, M. M. (2003). Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport. J. Membr. Biol. 193, 121–136.

Francois, J. (1975). The importance of the mucopolysaccharides in intraocular pressure regulation. Invest. Ophthalmol. 14, 173–176.

Friedenwald, J. S. (1937). Contribution to the theory and practice of tonometry. Am. J. Ophthalmol. 20, 985–1024.

Fuchshofer, R., Yu, A. H., Welge Lussen, U., and Tamm, E. R. (2007). Bone morphogenetic protein 7 is an antagonist of transforming growth factor beta2 in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 48, 715–726.

Fujisawa, N. (1994). Dexamethasone eVects of protein synthesis on organ cultured human trabecular meshwork autoradiographical, biochemical, and immunohistochemical study.

Nippon Ganka Gakkai Zasshi 98, 31–37.

Gabelt, B. T., and Kaufman, P. L. (2005). Changes in aqueous humor dynamics with age and glaucoma. Prog. Retin Eye Res. 24, 612–637.

Gabelt, B. T., Okka, M., Dean, T. R., and Kaufman, P. L. (2005). Aqueous humor dynamics in monkeys after topical R DOI. Invest. Ophthalmol. Vis. Sci. 46, 4691–4696.

Gabelt, B. T., Hu, Y., Vittitow, J. L., Rasmussen, C. R., Grosheva, I., Bershadsky, A. D., Geiger, B., Borras, T., and Kaufman, P. L. (2006). Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ cultured human and monkey anterior segments. Exp. Eye Res. 82, 935–944.

Glennon, R. A., Bondarev, M. L., Khorana, N., Young, R., May, J. A., Hellberg, M. R., McLaughlin, M. A., and Sharif, N. A. (2004). Beta oxygenated analogues of the 5 HT2A serotonin receptor agonist 1 (4 bromo 2,5 dimethoxyphenyl) 2 aminopropane. J. Med. Chem. 47, 6034–6041.

Gordon, M. O., Ocular Hypertension Treatment Study Group and European Prevention Treatment Study Group (2007). Validated prediction model for the development of primary open angle glaucoma in individuals with ocular hypertension. Ophthalmology 114, 10–19.

Gottanka, J., Chan, D., Eichhorn, M., Lu¨tjen Drecoll, E., and Ethier, C. R. (2004). EVects of TGF beta2 in perfused human eyes. Invest. Ophthalmol. Vis. Sci. 45, 153–158.

GriYn, B. W., Williams, G. W., Crider, J. Y., and Sharif, N. A. (1997). FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: A pharmacological study. J. Pharmacol. Exp. Ther. 281, 845–854.

Hejkal, T. W., and Camras, C. B. (1999). Prostaglandin analogs in the treatment of glaucoma.

Semin. Ophthalmol. 14, 114–123.

Herkel, U., and PfeiVer, N. (2001). Update on topical carbonic anhydrase inhibitors. Curr. Opin. Ophthalmol. 12, 88–93.

Ho, S. L., Dogar, G. F., Wang, J., Crean, J., Wu, Q. D., Oliver, N., Weitz, S., Murray, A., Cleary, P. E., and O’Brien, C. (2005). Elevated aqueous humour tissue inhibitor of matrix metalloproteinase 1 and connective tissue growth factor in pseudoexfoliation syndrome.

Br. J. Ophthalmol. 89, 169–173.

Hoare, M. J., Grierson, I., Brotchie, D., Pollock, N., Cracknell, K., and Clark, A. F. (2008). Cross linked actin networks (CLANs) in unmanipulated trabecular meshwork tissues of the human eye. Submitted.

HoVman, L. M., Maguire, A. M., and Bennett, J. (1997). Cell mediated immune response and stability of intraocular transgene expression after adenovirus mediated delivery. Invest. Ophthalmol. Vis. Sci. 38, 2224–2233.

Hong, S., Seong, G. J., and Hong, Y. J. (2007). Long term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch. Ophthalmol. 125, 1010–1013.

Honjo, M., Inatani, M., Kido, N., Sawamura, T., Yue, B. Y., Honda, Y., and Tanihara, H. (2001a). EVects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch. Ophthalmol. 119, 1171–1178.

Honjo, M., Tanihara, H., Inatani, M., Kido, N., Sawamura, T., Yue, B. Y., Narumiya, S., and Honda, Y. (2001b). EVects of rho associated protein kinase inhibitor Y 27632 on intraocular pressure and outflow facility. Invest. Ophthalmol. Vis. Sci. 42, 137–144.

Honjo, M., Inatani, M., Kido, N., Sawamura, T., Yue, B. Y., Honda, Y., and Tanihara, H. (2002). A myosin light chain kinase inhibitor, ML 9, lowers the intraocular pressure in rabbit eyes. Exp. Eye Res. 75, 135–142.

Hosseini, M., Rose, A. Y., Song, K., Bohan, C., Alexander, J. P., Kelley, M. J., and Acott, T. S. (2006). IL 1 and TNF induction of matrix metalloproteinase 3 by c Jun N terminal kinase in trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 47, 1469–1476.

Hoyng, P. F., and van Beek, L. M. (2000). Pharmacological therapy for glaucoma: A review. Drugs 59, 411–434.

Hu, Y., Gabelt, B. T., and Kaufman, P. L. (2006). Monkey organ cultured anterior segments: Technique and response to H 7. Exp. Eye Res. 82, 1100–1108.

Hubbard, W. C., Johnson, M., Gong, H., Gabelt, B. T., Peterson, J. A., Sawhney, R., Freddo, T., and Kaufman, P. L. (1997). Intraocular pressure and outflow facility are unchanged following acute and chronic intracameral chondroitinase ABC and hyaluronidase in monkeys. Exp. Eye Res. 65, 177–190.

Jacobson, N., Andrews, M., Shepard, A. R., Nishimura, D., Searby, C., Fingert, J. H., Hageman, G., Mullins, R., Davidson, B. L., Kwon, Y. H., Alward, W. L., Stone, E. M., et al. (2001). Non secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum. Mol. Genet. 10, 117–125.

Joe, M. K., Sohn, S., Hur, W., Moon, Y., Choi, Y. R., and Kee, C. (2003). Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem. Biophys. Res. Commun. 312, 592–600.

Johnson, D. H. (1997). The eVect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. Invest. Ophthalmol. Vis. Sci. 38, 2790–2799.

Johnson, D. H., Bradley, J. M., and Acott, T. S. (1990). The eVect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Invest. Ophthalmol. Vis. Sci. 31, 2568–2571.

Karl, M. O., Fleischhauer, J. C., Stamer, W. D., Peterson Yantorno, K., Mitchell, C. H., Stone, R. A., and Civan, M. M. (2005). DiVerential P1 purinergic modulation of human Schlemm’s canal inner wall cells. Am. J. Physiol. Cell Physiol. 288, C784–C794.

Kass, M. A., Heuer, D. K., Higginbotham, E. J., Johnson, C. A., Keltner, J. L., Miller, J. P., Parrish, R. K., Wilson, M. R., and Gordon, M. O. (2002). The ocular hypertension treatment study—a randomized trial determines that topcial ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch. Ophthalmol. 120, 701–713.

Kaufman, P. L., and Ba´ra´ny, E. H. (1977). Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 16, 47–53.

Kaufman, P. L., Jia, W. W., Tan, J., Chen, Z., Gabelt, B. T., Booth, V., Tufaro, F., and Cynader, M. (1999). A perspective of gene therapy in the glaucomas. Surv. Ophthalmol. 43(Suppl 1), S91–S97.

Kee, C., and Seo, K. (1997). The eVect of interleukin 1alpha on outflow facility in rat eyes.

J. Glaucoma 6, 246–249.

Kee, C., Sohn, S., and Hwang, J. M. (2001). Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest. Ophthalmol. Vis. Sci. 42, 2856–2860.

Kelley, M. J., Rose, A., Song, K., Lystrup, B., Samples, J. W., and Acott, T. S. (2007a). p38 MAP kinase pathway and stromelysin regulation in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 48, 3126–3137.

Kelley, M. J., Rose, A. Y., Song, K., Chen, Y., Bradley, J. M., Rookhuizen, D., and Acott, T. S. (2007b). Synergism of TNF and IL 1 in the induction of matrix metalloproteinase 3 in trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 48, 2634–2643.

Knepper, P. A., Breen, M., Weinstein, H. G., and Blacik, J. L. (1978). Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: EVect of age and dexamethasone. Exp. Eye Res. 27, 567–575.

Knepper, P. A., Collins, J. A., and Frederick, R. (1985a). EVects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 26, 1093–1100.

Knepper, P. A., Goossens, W., Hvizd, M., and Palmberg, P. F. (1996a). Glycosaminoglycans of the human trabecular meshwork in primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 37, 1360–1367.

Knepper, P. A., Goossens, W., and Palmberg, P. F. (1996b). Glycosaminoglycan stratification of the juxtacanalicular tissue in normal and primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 37, 2414–2425.

Knepper, P. A., Goossens, W., and Mayanil, C. S. (1998). CD44H localization in primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 39, 673–680.

Knepper, P. A., and McLone, D. G. (1985b). Glycosaminoglycans and outflow pathways of the eye and brain. Pediatr. Neurosci. 12, 240–251.

Knepper, P. A., Miller, A. M., Choi, J., Wertz, R. D., Nolan, M. J., Goossens, W., Whitmer, S., Yue, B. Y., Ritch, R., Liebmann, J. M., Allingham, R. R., and Samples, J. R. (2005). Hypophosphorylation of aqueous humor sCD44 and primary open angle glaucoma. Invest. Ophthalmol. Vis. Sci. 46, 2829–2837.

Koga, T., Koga, T., Awai, M., Tsutsui, J., Yue, B. Y., and Tanihara, H. (2006). Rho associated protein kinase inhibitor, Y 27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells. Exp. Eye Res. 82, 362–370.

Konno, T., Ohnuma, S. Y., Uemoto, K., Uchibori, T., Nagai, A., Kogi, K., Endo, K., Hosokawa, T., and Nakahata, N. (2004). EVects of 2 alkynyladenosine derivatives on intraocular pressure in rabbits. Eur. J. Pharmacol. 486, 307–316.

Konno, T., Murakami, A., Uchibori, T., Nagai, A., Kogi, K., and Nakahata, N. (2005a). Involvement of adenosine A(2a) receptor in intraocular pressure decrease induced by 2 (1 octyn 1 yl)adenosine or 2 (6 cyano 1 hexyn 1 yl) adenosine. J. Pharmacol. Sci. 97, 501–509.

Konno, T., Uchibori, T., Nagai, A., Kogi, K., and Nakahata, N. (2005b). 2 (1 Hexyn 1 yl) adenosine induced intraocular hypertension is mediated via Kþ channel opening through adenosine A(2A) receptor in rabbits. Eur. J. Pharmacol. 518, 203–211.

Langham, M. E. (1979). The physiology and pathology of the intraocular pressure. In ‘‘Glaucoma: Contemporary International Concepts’’ (J. G. Bellows, ed.), pp. 24–48. Masson Publishing, New York.

Larsson, L. I., Rettig, E. S., and Brubaker, R. F. (1995). Aqueous flow in open angle glaucoma.

Arch. Ophthalmol. 113, 283–286.

Leske, M. C., Heijl, A., Hussein, M., Bengtsson, B., Hyman, L., and KomaroV, E. (2003). Factors for glaucoma progression and the eVect of treatment: The early manifest glaucoma trial. Arch. Ophthalmol. 121, 48–56.

Li, J., Tripathi, B. J., and Tripathi, R. C. (2000). Modulation of pre mRNA splicing and protein production of fibronectin by TGF beta2 in porcine trabecular cells. Invest. Ophthalmol. Vis. Sci. 41, 3437–3443.

Lichter, P. R., Musch, D. C., Gillespie, B. W., Guire, K. E., Janz, N. K., Wren, P. A., and Mills, R. P. (2001). Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108, 1943–1953.

Linden, C. (2001). Therapeutic potential of prostaglandin analogues in glaucoma. Expert Opin. Investig. Drugs 10, 679–694.

Lindsey, J. D., Kashiwagi, K., Boyle, D., Kashiwagi, F., Firestein, G. S., and Weinreb, R. N. (1996). Prostaglandins increase proMMP 1 and proMMP 3 secretion by human ciliary smooth muscle cells. Curr. Eye Res. 15, 869–875.

Lindsey, J. D., Kashiwagi, K., Kashiwagi, F., and Weinreb, R. N. (1997). Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow. Surv. Ophthalmol. 41(Suppl 2), S53–S59.

Linner, E. (1976). Ocular hypertension. I. The clinical course during ten years without therapy. Aqueous humour dynamics. Acta Ophthalmol. 54, 707–720.

Liton, P. B., Liu, X., Challa, P., Epstein, D. L., and Gonzalez, P. (2005). Induction of TGF beta1 in the trabecular meshwork under cyclic mechanical stress. J. Cell Physiol. 205, 364–371.

Liton, P. B., Luna, C., Challa, P., Epstein, D. L., and Gonzalez, P. (2006). Genome wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue. Mol. Vis. 12, 774–790.

Liu, X., Brandt, C. R., Gabelt, B. T., Bryar, P. J., Smith, M. E., and Kaufman, P. L. (1999). Herpes simplex virus mediated gene transfer to primate ocular tissues. Exp. Eye Res. 69, 385–395.

Liu, X., Hu, Y., Filla, M. S., Gabelt, B. T., Peters, D. M., Brandt, C. R., and Kaufman, P. L. (2005). The eVect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol. Vis. 11, 1112–1121.

Loewen, N., Fautsch, M. P., Peretz, M., Bahler, C. K., Cameron, J. D., Johnson, D. H., and Poeschla, E. M. (2001). Genetic modification of human trabecular meshwork with lentiviral vectors. Hum. Gene Ther. 12, 2109–2119.

Luo, Q., Kang, Q., Si, W., Jiang, W., Park, J. K., Peng, Y., Li, X., Luu, H. H., Luo, J., Montag, A. G., Haydon, R. C., and He, T. C. (2004). Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast diVerentiation of mesenchymal stem cells. J. Biol. Chem. 279, 55958–55968.

Lu¨tjen Drecoll, E. (2005). Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp. Eye Res. 81, 1–4.

Lu¨tjen Drecoll, E., Shimizu, T., Rohrbach, M., and Rohen, J. W. (1986). Quantitative analysis of ‘plaque material’ between ciliary muscle tips in normal and glaucomatous eyes. Exp. Eye Res. 42, 457–465.

Mabuchi, F., Lindsey, J. D., Aihara, M., Mackey, M. R., and Weinreb, R. N. (2004). Optic nerve damage in mice with a targeted type I collagen mutation. Invest. Ophthalmol. Vis. Sci. 45, 1841–1845.

May, J. A., Chen, H. H., Rusinko, A., Lynch, V. M., Sharif, N. A., and McLaughlin, M. A. (2003a). A novel and selective 5 HT2 receptor agonist with ocular hypotensive activity:

(S) (þ) 1 (2 aminopropyl) 8,9 dihydropyrano[3,2 e]indole. J. Med. Chem. 46, 4188–4195. May, J. A., McLaughlin, M. A., Sharif, N. A., Hellberg, M. R., and Dean, T. R. (2003b).

Evaluation of the ocular hypotensive response of serotonin 5 HT1A and 5 HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J. Pharmacol. Exp. Ther. 306, 301–309.

May, J. A., Dantanarayana, A. P., Zinke, P. W., McLaughlin, M. A., and Sharif, N. A. (2006). 1 ((S) 2 aminopropyl) 1H indazol 6 ol: A potent peripherally acting 5 HT2 receptor agonist with ocular hypotensive activity. J. Med. Chem. 49, 318–328.

Melamed, S., Kotas Neumann, R., Barak, A., and Epstein, D. L. (1992). The eVect of intracamerally injected ethacrynic acid on intraocular pressure in patients with glaucoma. Am. J. Ophthalmol. 113, 508–512.

Melton, C. E., and DeVille, W. B. (1960). Perfusion studies on eyes of four species. Am. J. Ophthalmol. 50, 302–308.

Mitchell, C. H., Peterson Yantorno, K., Carre, D. A., McGlinn, A. M., Coca Prados, M., Stone, R. A., and Civan, M. M. (1999). A3 adenosine receptors regulate Cl channels of nonpigmented ciliary epithelial cells. Am. J. Physiol. 276, C659–C666.

Nguyen, T. D., Chen, P., Huang, W. D., Chen, H., Johnson, D., and Polansky, J. R. (1998). Gene structure and properties of TIGR, an olfactomedin related glycoprotein cloned from glucocorticoid induced trabecular meshwork cells. J. Biol. Chem. 273, 6341–6350.

Nishanian, T. G., Kim, J. S., Foxworth, A., and Waldman, T. (2004). Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol. Ther. 3, 667–675.

Nolan, M. J., Giovingo, M. C., Miller, A. M., Wertz, R. D., Ritch, R., Liebmann, J. M., Allingham, R. R., Herndon, L. W., Wax, M. B., Smolyak, R., Hasan, F., Barnett, E. M., et al. (2007). Aqueous humor sCD44 concentration and visual field loss in primary open angle glaucoma. J. Glaucoma 16, 419–429.

Nouri Mahdavi, K., HoVman, D., Coleman, A. L., Liu, G., Li, G., Gaasterland, D., and Caprioli, J. (2004). Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study. Ophthalmology 111, 1627–1635.

Novack, G. D. (1987). Ophthalmic beta blockers since timolol. Surv. Ophthalmol. 31, 307–327. O’Brien, C., Schwartz, B., Takamoto, T., and Wu, D. C. (1991). Intraocular pressure and the rate of visual field loss in chronic open angle glaucoma. Am. J. Ophthalmol. 111, 491–500. O’Donnell, M. E., Brandt, J. D., and Curry, F. R. (1995). Na K Cl cotransport regulates intracellular volume and monolayer permeability of trabecular meshwork cells. Am. J.

Physiol. 268, C1067–C1074.

Okamura, T., Kurogi, Y., Hashimoto, K., Sato, S., Nishikawa, H., Kiryu, K., and Nagao, Y. (2004). Structure activity relationships of adenosine A3 receptor ligands: New potential therapy for the treatment of glaucoma. Bioorg. Med. Chem. Lett. 14, 3775–3779.

Okka, M., Tian, B., and Kaufman, P. L. (2004a). EVect of low dose latrunculin B on anterior segment physiologic features in the monkey eye. Arch. Ophthalmol. 122, 1482–1488.

Okka, M., Tian, B., and Kaufman, P. L. (2004b). EVects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys. Trans. Am. Ophthalmol. Soc. 102, 251–257.

OlthoV, C. M., Schouten, J. S., van de Borne, B. W., and Webers, C. A. (2005). Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence based review. Ophthalmology 112, 953–961.

Pang, I. H., Moll, H., McLaughlin, M. A., Knepper, P. A., De Santis, L., Epstein, D. L., and Clark, A. F. (2001). Ocular hypotensive and aqueous outflow enhancing eVects of AL 3037A (sodium ferri ethylenediaminetetraacetate). Exp. Eye Res. 73, 815–825.

Pang, I. H., Fleenor, D. L., Hellberg, P. E., Stropki, K., McCartney, M. D., and Clark, A. F. (2003a). Aqueous outflow enhancing eVect of tert butylhydroquinone: Involvement of AP 1 activation and MMP 3 expression. Invest. Ophthalmol. Vis. Sci. 44, 3502–3510.

Pang, I. H., Hellberg, P. E., Fleenor, D. L., Jacobson, N., and Clark, A. F. (2003b). Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells.

Invest. Ophthalmol. Vis. Sci. 44, 3485–3493.

Parshley, D. E., Bradley, J. M., Samples, J. R., Van Buskirk, E. M., and Acott, T. S. (1995). Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr. Eye Res. 14, 537–544.

Parshley, D. E., Bradley, J. M., Fisk, A., Hadaegh, A., Samples, J. R., Van Buskirk, E. M., and Acott, T. S. (1996). Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest. Ophthalmol. Vis. Sci. 37, 795–804.

Pedler, C. (1956). The relationship of hyaluronidase to aqueous outflow resistance. Trans. Ophthalmol. Soc. UK 76, 51–63.

Peterson, W. S., and Jocson, V. L. (1974). Hyaluronidase eVects on aqueous outflow resistance. Quantitative and localizing studies in the rhesus monkey eye. Am. J. Ophthalmol. 77, 573–577.

Quigley, H. A., and Broman, A. T. (2006). The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262–267.

Rao, P. V., Deng, P. F., Kumar, J., and Epstein, D. L. (2001). Modulation of aqueous humor outflow facility by the Rho kinase specific inhibitor Y 27632. Invest. Ophthalmol. Vis. Sci. 42, 1029–1037.

Rao, P. V., Deng, P., Maddala, R., Epstein, D. L., Li, C. Y., and Shimokawa, H. (2005a). Expression of dominant negative Rho binding domain of Rho kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol. Vis. 11, 288–297.

Rao, P. V., Deng, P., Sasaki, Y., and Epstein, D. L. (2005b). Regulation of myosin light chain phosphorylation in the trabecular meshwork: Role in aqueous humour outflow facility.

Exp. Eye Res. 80, 197–206.

Rao, P. V., Shimazaki, A., Ichikawa, M., Alvarado, J. A., and Epstein, D. L. (2005c). EVects of novel ethacrynic acid derivatives on human trabecular meshwork cell shape, actin cytoskeletal organization, and transcellular fluid flow. Biol. Pharm. Bull. 28, 2189–2196.

Read, A. T., Chan, D. W., and Ethier, C. R. (2007). Actin structure in the outflow tract of normal and glaucomatous eyes. Exp. Eye Res. 84, 214–226.

Richter, M., Krauss, A. H., Woodward, D. F., and Lu¨tjen Drecoll, E. (2003). Morphological changes in the anterior eye segment after long term treatment with diVerent receptor selective prostaglandin agonists and a prostamide. Invest. Ophthalmol. Vis. Sci. 44, 4419–4426.

Robin, A. L. (1997). The role of alpha agonists in glaucoma therapy. Curr. Opin. Ophthalmol. 8, 42–49.

Robinson, J. C., and Kaufman, P. L. (1991). Cytochalasin B potentiates epinephrine’s outflow facility increasing eVect. Invest. Ophthalmol. Vis. Sci. 32, 1614–1618.

Rohen, J. W. (1983). Why is intraocular pressure elevated in chronic simple glaucoma? Anatomical considerations. Ophthalmology 90, 758–765.

Rosenthal, R., Choritz, L., Schlott, S., Bechrakis, N. E., Jaroszewski, J., Wiederholt, M., and Thieme, H. (2005). EVects of ML 7 and Y 27632 on carbachol and endothelin 1 induced contraction of bovine trabecular meshwork. Exp. Eye Res. 80, 837–845.

Sabanay, I., Tian, B., Gabelt, B. T., Geiger, B., and Kaufman, P. L. (2004). Functional and structural reversibility of H 7 eVects on the conventional aqueous outflow pathway in monkeys. Exp. Eye Res. 78, 137–150.

Sabanay, I., Tian, B., Gabelt, B. T., Geiger, B., and Kaufman, P. L. (2006). Latrunculin B eVects on trabecular meshwork and corneal endothelial morphology in monkeys. Exp. Eye Res. 82, 236–246.

Samples, J. R., Alexander, J. P., and Acott, T. S. (1993). Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin 1 and dexamethasone.

Invest. Ophthalmol. Vis. Sci. 34, 3386–3395.

Sawaguchi, S., Yue, B., Yeh, P., and Tso, M. O. M. (1992). EVects of intracameral injection of chondroitinase ABC in vivo. Arch. Ophthalmol. 110, 110–117.

Sawaguchi, S., Lam, T. T., Yue, B. Y., and Tso, M. O. M. (1993). EVects of glycosaminoglycan degrading enzymes on bovine trabecular meshwork in organ culture. J. Glaucoma 2, 80–86.

Schlotzer Schrehardt, U., Zenkel, M., Kuchle, M., Sakai, L. Y., and Naumann, G. O. (2001). Role of transforming growth factor beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp. Eye Res. 73, 765–780.

Schwartz, G. F. (2005). Compliance and persistency in glaucoma follow up treatment. Curr. Opin. Ophthalmol. 16, 114–121.

Segawa, K. (1979). Electron microscopic changes in the trabecular tissue in primary open angle glaucoma. In ‘‘Glaucoma: Contemporary International Concepts’’ (J. G. Bellows, ed.), pp. 17–23. Masson Publishing, New York.

Sharif, N. A., Kelly, C. R., and McLaughlin, M. (2006). Human trabecular meshwork cells express functional serotonin 2A (5HT2A) receptors: Role in IOP reduction. Invest. Ophthalmol. Vis. Sci. 47, 4001–4010.

Shepard, A. R., Fleenor, D., Jacobson, N., Pang, I. H., and Clark, A. F. (2003). Connective tissue growth factor expression In glaucomatous human TM cells and aqueous humor and upregulation by TGF beta2. ARVO Abstract 3161.

Shepard, A. R., Jacobson, N., Millar, J. C., Pang, I. H., Steely, H. T., Searby, C. C., SheYeld, V. C., Stone, E. M., and Clark, A. F. (2007). Glaucoma causing myocilin mutants require he Peroxisomal Targeting Signal 1 Receptor (PTS1R) to elevate intraocular pressure. Hum. Mol. Genet. 16, 609–617.

Shepard, A. R., Nolan, M. J., Millar, J. C., Pang, I. H., Luan, T., Jacobson, N., Wax, M. B., Clark, A. F., and Knepper, P. A. (2008). CD44 overexpression causes ocular hypertension in mouse. ARVO Abstract 2008, 2880.

Shimazaki, A., Ichikawa, M., Rao, P. V., Kirihara, T., Konomi, K., Epstein, D. L., and Hara, H. (2004a). EVects of the new ethacrynic acid derivative SA9000 on intraocular pressure in cats and monkeys. Biol. Pharm. Bull. 27, 1019–1024.

Shimazaki, A., Suhara, H., Ichikawa, M., Matsugi, T., Konomi, K., Takagi, Y., Hara, H., Rao, P. V., and Epstein, D. L. (2004b). New ethacrynic acid derivatives as potent cytoskeletal modulators in trabecular meshwork cells. Biol. Pharm. Bull. 27, 846–850.

Steely, H. T., Browder, S. L., Julian, M. B., Miggans, S. T., Wilson, K. L., and Clark, A. F. (1992). The eVects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 33, 2242–2250.

Stewart, W. C., Kolker, A. E., Sharpe, E. D., Day, D. G., Holmes, K. T., Leech, J. N., Johnson, M., and Cantrell, J. B. (2000). Factors associated with long term progression or stability in primary open angle glaucoma. Am. J. Ophthalmol. 130, 274–279.

Stone, E. M., Fingert, J. H., Alward, W. L. M., Nguyen, T. D., Polansky, J. R., Sunden, S. L. F., Nishimura, D., Clark, A. F., Nystuen, A., Nichols, B. E., Mackey, D. A., Ritch, R., et al. (1997). Identification of a gene that causes primary open angle glaucoma. Science 275, 668–670.

Sugrue, M. F. (2000). Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog. Retin Eye Res. 19, 87–112.

Svedbergh, B., Lu¨tjen Drecoll, E., Ober, M., and Kaufman, P. L. (1978). Cytochalasin B induced structural changes in the anterior ocular segment of the cynomolgus monkey.

Invest. Ophthalmol. Vis. Sci. 17, 718–734.

Tamm, E. R., Siegner, A., Baur, A., and Lu¨tjen Drecoll, E. (1996). Transforming growth factor beta 1 induces alpha smooth muscle actin expression in cultured human and monkey trabecular meshwork. Exp. Eye Res. 62, 389–397.

Thieme, H., Schimmat, C., Munzer, G., Boxberger, M., Fromm, M., PfeiVer, N., and Rosenthal, R. (2006). Endothelin antagonism: EVects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest. Ophthalmol. Vis. Sci. 47, 938–945.

Tian, B., and Kaufman, P. L. (2005). EVects of the Rho kinase inhibitor Y 27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp. Eye Res. 80, 215–225.

Tian, B., Gabelt, B. T., Crosson, C. E., and Kaufman, P. L. (1997). EVects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp. Eye Res. 64, 979–989.

Tian, B., Brumback, L. C., and Kaufman, P. L. (2000a). ML 7, chelerythrine and phorbol ester increase outflow facility in the monkey Eye. Exp. Eye Res. 71, 551–566.

Tian, B., Geiger, B., Epstein, D. L., and Kaufman, P. L. (2000b). Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest. Ophthalmol. Vis. Sci. 41, 619–623.

Tian, B., Kiland, J. A., and Kaufman, P. L. (2001). EVects of the marine macrolides swinholide A and jasplakinolide on outflow facility in monkeys. Invest. Ophthalmol. Vis. Sci. 42, 3187–3192.

Tian, B., Wang, R. F., Podos, S. M., and Kaufman, P. L. (2004). EVects of topical H 7 on outflow facility, intraocular pressure, and corneal thickness in monkeys. Arch. Ophthalmol. 122, 1171–1177.

Tokushige, H., Inatani, M., Nemoto, S., Sakaki, H., Katayama, K., Uehata, M., and Tanihara, H. (2007). EVects of topical administration of y 39983, a selective rho associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest. Ophthalmol. Vis. Sci. 48, 3216–3222.

Toris, C. B., Koepsell, S. A., Yablonski, M. E., and Camras, C. B. (2002). Aqueous humor dynamics in ocular hypertensive patients. J. Glaucoma 11, 253–258.

Tovar Vidales, T., Roque, R., Clark, A. F., and Wordinger, R. J. (2008). Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues. Invest Ophthalmol. Vis. Sci. 49, 622–628.

Tripathi, R. C., Borisuth, N. S., Kolli, S. P., and Tripathi, B. J. (1993a). Trabecular cells express receptors that bind TGF beta 1 and TGF beta 2: A qualitative and quantitative characterization. Invest. Ophthalmol. Vis. Sci. 34, 260–263.

Tripathi, R. C., Li, J., Borisuth, N. S., and Tripathi, B. J. (1993b). Trabecular cells of the eye express messenger RNA for transforming growth factor beta 1 and secrete this cytokine.

Invest. Ophthalmol. Vis. Sci. 34, 2562–2569.

Usui, T., Nakajima, F., Ideta, R., Kaji, Y., Suzuki, Y., Araie, M., Miyauchi, S., Heldin, P., and Yamashita, H. (2003). Hyaluronan synthase in trabecular meshwork cells. Br. J. Ophthalmol. 87, 357–360.

Van Buskirk, E. M., and Brett, J. (1978). The canine eye: In vitro studies of the intraocular pressure and facility of aqueous outflow. Invest. Ophthalmol. Vis. Sci. 17, 373–377.

van Setten, G. B., Blalock, T. D., Grotendorst, G., and Schultz, G. S. (2002). Detection of connective tissue growth factor in human aqueous humor. Ophthalmic. Res. 34, 306–308.

Waki, M., Yoshida, Y., Oka, T., and Azuma, M. (2001). Reduction of intraocular pressure by topical administration of an inhibitor of the Rho associated protein kinase. Curr. Eye Res. 22, 470–474.

Wang, N., Chintala, S. K., Fini, M. E., and Schuman, J. S. (2001). Activation of a tissue specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat. Med. 7, 304–309.

Wang, W. H., McNatt, L. G., Pang, I. H., Hellberg, P. E., Fingert, J. H., McCartney, M. D., and Clark, A. F. (2008). Increased expression of serum amyloid A in glaucoma and its eVect on intraocular pressure. Invest Ophthalmol. Vis. Sci. 49, 1916–1923.

Wang, W. H., McNatt, L. G., Hellberg, P. E., Pang, I. H., Millar, J. C., Steely, H. T., Rubin, J. S., Fingert, J. H., SheYeld, V. C., Stone, E. M., and Clark, A. F. (2008). Increased expression of the wnt antagonist/elevates intraocular pressure sFRP1 in glaucoma. J. clin Invest 118, 1056–1064.

Weinreb, R. N. (2000). Uveoscleral outflow: The other outflow pathway. J. Glaucoma 9, 343–345.

Welge Lussen, U., May, C. A., and Lu¨tjen Drecoll, E. (2000). Induction of tissue transglutaminase in the trabecular meshwork by TGF beta1 and TGF beta2. Invest. Ophthalmol. Vis. Sci. 41, 2229–2238.

Wordinger, R. J., and Clark, A. F. (2007). Bone morphogenetic proteins and their receptors in the eye. Exp. Biol. Med. 232, 979–992.

Wordinger, R. J., and Clark, A. F. (2008). Growth factors and neurotrophic factors as targets. In ‘‘Ocular Therapeutics: Eye on New Discoveries’’ (T. Yorio, A. F. Clark, and M. B. Wax, eds.). Elsevier Ltd., Bostom. pp 87–116.

Wordinger, R. J., Clark, A. F., Agarwal, R., Lambert, W., McNatt, L., Wilson, S. E., Qu, Z., and Fung, B. K. (1998). Cultured human trabecular meshwork cells express functional growth factor receptors. Invest. Ophthalmol. Vis. Sci. 39, 1575–1589.

Wordinger, R. J., Agarwal, R., Talati, M., Fuller, J., Lambert, W., and Clark, A. F. (2002). Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol. Vis. 8, 241–250.

Wordinger, R. J., Fleenor, D. L., Pang, I. H., Tovar, T., Zode, G., Fuller, J., and Clark, A. F. (2007). Gremlin inhibits Bone Morphogenetic Protein 4 (BMP 4) antagonism of TGFb2 function in cultured human trabecular cells and in the perfused anterior eye organ culture model. Invest. Ophthalmol. Vis. Sci. 48, 1191–1200.

Yang, H., Avila, M. Y., Peterson Yantorno, K., Coca Prados, M., Stone, R. A., Jacobson, K. A., and Civan, M. M. (2005). The cross species A3 adenosine receptor antagonist MRS 1292 inhibits adenosine triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure. Curr. Eye Res. 30, 747–754.

Zhang, X., Schroeder, A., Callahan, E. M., Coyle, B. M., Wang, N., Erickson, K. A., Schuman, J. S., and Fini, M. E. (2006). Constitutive signalling pathway activity in trabecular meshwork cells from glaucomatous eyes. Exp. Eye Res. 82, 968–973.

Zhao, X., and Russell, P. (2005). Versican splice variants in human trabecular meshwork and ciliary muscle. Mol. Vis. 11, 603–608.

Zhao, X., Ramsey, K. E., Stephan, D. A., and Russell, P. (2004). Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor beta.

Invest. Ophthalmol. Vis. Sci. 45, 4023–4034.